November 28, 2020

The Niche

Knoepfler lab stem cell blog

Doudna most deserving of CRISPR Cas9 patent, says poll

CRISPR Patent Poll
CRISPR Patent Poll.

With more than 250 votes cast, Jennifer Doudna is leading by a decisive margin in a poll
asking who deserves the patent for use of CRISPR-Cas9 as a tool.

Feng Zhang got only just over half the votes of Doudna.

Another take home message from this poll is that a sizable minority–almost one in five– said neither should have a patent on this technology.

Geographically the results were fairly consistent across countries, but notably in the UK the top response was, “Neither”.

This poll is of course non-scientific, but it is interesting even so to see a fairly decisive result.

Let’s see ultimately what happens with the US Patent Office.

Here’s an update from 2020 on the CRISPR patent battle. How can it still be going on?

%d bloggers like this: